Severe Traumatic Brain Injury Completed Phase 1 Trials for Conivaptan (DB00872)

IndicationStatusPhase
DBCOND0037364 (Severe Traumatic Brain Injury)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00930202Study of the Safety and Efficacy of Conivaptan (Vaprisol®) to Raise Serum Sodium Levels in Patients With Severe Traumatic Brain InjuryTreatment